Latest News
Stoke Therapeutics, Inc.
- Stoke Therapeutics, Inc. Estimates – BOATS:STOK
- Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2026 Business and Financial Updates
- Form 144 STOKE THERAPEUTICS For: 21 October
- Stoke Therapeutics eyes 2027 readout for potent...
- Stoke Therapeutics: The Market Misread A Key FDA Win (NASDAQ:STOK)
- Stoke Therapeutics Announces Inducement Grants
- Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Stoke aligns with FDA on plan to file NDA for zorevunersen in Dravet syndrome
- Stoke Therapeutics details Dravet cognition analysis after FDA meeting
- Stoke Therapeutics aligns with FDA on zorevunersen NDA submission By Investing.com
- Ruth Walker Appointed Vice President, People & Culture at Stoke Therapeutics
- Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, E
Headlines from the last 30 days, linking to the original publishers. See all market news →